MedPage Today on MSN
Third-Generation PCSK9 Inhibitor Approved for High Cholesterol
A third-generation PCSK9 inhibitor, lerodalcibep is indicated as an adjunct to diet and exercise to reduce LDL cholesterol in ...
Resistance to venetoclax (Venclexta® and Venclyxto®, Abbvie / Genentech), the $2.5 billion blockbuster Chronic Lymphocytic ...
Clinical guidelines are vague, so we asked psychiatrists what to consider when deciding whether to continue taking these ...
Resistance to venetoclax (Venclexta® and Venclyxto®, Abbvie / Genentech), the $2.5 billion blockbuster Chronic Lymphocytic Leukemia (CLL) therapy, is emerging as a ...
News Medical on MSN
AI-guided discovery of selective DGKα inhibitors to overcome checkpoint resistance in solid cancers
Insilico Medicine has developed a new class of small molecule inhibitors targeting diacylglycerol kinase alpha (DGKα) designed to restore T cell function and overcome resistance to immune checkpoint ...
News-Medical.Net on MSN
Immune checkpoint inhibitors can trigger rare immune thrombocytopenia in cancer patients
Researchers led by investigators at Mass General Brigham have published valuable information about a rare but serious complication of anti-cancer immunotherapy, providing the first large-scale ...
The so-called "Oroya fever" is an extremely severe infectious disease, yet it is classified among the so-called neglected ...
Researchers at MIT and Stanford University have developed a new way to stimulate the immune system to attack tumor cells, using a strategy that could make cancer immunotherapy work for many more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback